Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled PeriodAnthony A. Portale, Karl Insogna, Thomas O. Carpenter et al.|Calcified Tissue International|2019Cited by 160
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry RegistryAlberto Ortíz, David G. Warnock, Ademola K. Abiose et al.|Journal of Medical Genetics|2016Cited by 147
Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya diseaseEunhee Kim, Han‐Wook Yoo, Gu-Hwan Kim et al.|Journal of neurosurgery|2015Cited by 116
Identification of 15 loci influencing height in a Korean populationJae-Jung Kim, Jong‐Keuk Lee, Hae-In Lee et al.|Journal of Human Genetics|2009Cited by 114
PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype–phenotype correlation in Korean patients with Noonan syndromeJung Min Ko, Han‐Wook Yoo, Jae‐Min Kim et al.|Journal of Human Genetics|2008Cited by 108